This little-known medical technology stock can rally more than 40%, Jefferies says

Under The Radar News

This little-known medical technology stock can rally more than 40%, Jefferies says
Rxsight IncStock MarketsInvestment Strategy
  • 📰 CNBC
  • ⏱ Reading Time:
  • 23 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 72%

Jefferies is seeing a clearer outlook for shares of this maker of ocular implants

Jefferies sees a clear outlook for shares of RxSight . Analyst Young Li initiated coverage of the maker of ocular implants to resolve vision issues with a buy rating, citing its "unique" technology. He also placed a $72 price target on the stocks, reflecting 43% upside from Monday's close. "RXST makes the first and only post surgery adjustable intraocular lens to resolve cataracts. The differentiated and best in class tech enables premium , and share taking, from 10% U.S.

mountain Shares in 2024 The firm expects the company to hit this 50% market share milestone via solid clinical results, growing adoption and utilization trends. Li also views RxSight's $6 billion 2027 estimate for its light adjustable lens as too conservative. Checks suggest that nearly half of intraocular lens patients qualify, boosting the firm's confidence in modeling 45% LAL growth by the end of 2025 — ahead of consensus expectations.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Rxsight Inc Stock Markets Investment Strategy Business News

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

D-backs Top 40 Prospects in 2024: No. 40 Jacob SteinmetzD-backs Top 40 Prospects in 2024: No. 40 Jacob SteinmetzThis article is part of a series reviewing the seasons of the top 40 prospects still in the Arizona Diamondbacks system as of the end of 2024. Jacob Steinmetz,
Read more »

3 defensive gems that ended up denying José Ramírez entry to the 40/40 club3 defensive gems that ended up denying José Ramírez entry to the 40/40 clubJosé Ramírez was robbed of at least three potential home runs during the regular season by opposing outfielders.
Read more »

Colorado woman runs 2,200-mile Appalachian Trail in 40 days, beating fastest known time recordColorado woman runs 2,200-mile Appalachian Trail in 40 days, beating fastest known time recordA professional runner from Colorado recently completed the 2,189-mile Appalachian Trail in a record 40 days time. She told Fox News Digital about her experience.
Read more »

Jefferies says buy this little-known injectable drug delivery maker with more than 30% upsideJefferies says buy this little-known injectable drug delivery maker with more than 30% upsideIt's time to buy shares of this under-the-radar injectables delivery maker with more than 30% upside potential, according to Jefferies.
Read more »

10 Funniest Far Side Comics That Just Turned 40, Including Gary Larson's Funniest Cat Comic10 Funniest Far Side Comics That Just Turned 40, Including Gary Larson's Funniest Cat Comicfar side art of a cat and mouse throwing a ball back and forth
Read more »

Bitcoin Up 40% YTD But Underperforms Gold When Adjusted for RiskBitcoin Up 40% YTD But Underperforms Gold When Adjusted for RiskBitcoin has risen over 40% this year but the price surge doesn't compensate for the price volatility risks, according to a chart by Goldman Sachs. Bitcoin's year-to-date return to volatility ratio is under 2%, significantly lower than gold's industry-leading risk-adjusted return of around 3%. CoinDesk's Christine Lee presents the 'Chart of the Day.
Read more »



Render Time: 2025-02-16 13:18:24